Identification and Biological Activities of the Phenolic Compounds in <i>Eisenia arborea</i>
- 1 CEWIT Center for Systems Biology, The State University of New York, 119 Songdo Moonhwaro, Yeonsu-gu, Incheon, Korea
- 2 Baja Kelp Talasoterapia, Ensenada, Mexico
- 3 Department of Chemical and Biological Engineering, Hanbat National University, 125 Dongseodaero, Yuseong-gu, Daejeon, Korea
- 4 Department of Chemical and Biological Engineering, Hanbat National University, 125 Dongseodaero, Yuseong-gu, Daejeon, Korea
Abstract
Four polyphenols were isolated and purified from a brown alga Eisenia arborea . These phlorotannin compounds showed strong radical scavenging and some enzyme inhibitory activities. All of the compounds showed strong antioxidative, acetylcholinesterase and butyrylcholinesterase inhibitory, and tyrosinase inhbibitory activities at 100 μg/mL. Dieckol and PFF inhibited butyrylcholinesterase, a new target for the treatment of Alzheimer’s disease, very strongly even at 10 μg/mL , more strongly than AChE. These two compounds also effectively inhibited tyrosinase. These results support the potential of developing natural antioxidants and antidementia agents from the brown alga.
- Edwards, M.S. and Hernández-Carmona, G. (2005) Delayed Recovery of Giant Kelp Near Its Southern Range Limit in the North Pacific following El Nino. Marine Biology, 147, 273-279. https://doi.org/10.1007/s00227-004-1548-7
- Denisov, E.T. and Afanas’Ev, I.B. (2005) Free Radicals and Oxidative Stress in Pathophysiological Processes. Oxidation and Antioxidants in Organic Chemistry and Biology, CRC Press, Boca Raton, 905-950.
- Pietta, P.G. (2000) Flavonoids as Antioxidants. Journal of Natural Products, 63, 1035-1042. https://doi.org/10.1021/np9904509
- Huang, D., Boxin, O. and Prior, R.L. (2005) The Chemistry behind Antioxidant Capacity Assays. Journal of Agricultural and Food Chemistry, 23, 1841-1856. https://doi.org/10.1021/jf030723c
- Greig, N.H., Utsuki, T., Yu, Q., Zhu, X., Holloway, H.W., Perry, T., Lee, B.H., Ingram, D.K. and Lahiri, D.K. (2001) A New Therapeutic Target in Alzheimer’s Disease Treatment: Attention to Butyrylcholinesterase. Current Medical Research and Opinion, 17, 1-6.
- Greig, N.H., Sambamurti, K., Yu, Q.S., Perry, T.A., Holloway, H.W., Haberman, F., Brossi, A., Ingram, D.K. and Lahiri, D.K. (2003) Butyrylcholinesterase: Its Selective Inhibition and Relevance to Alzheimer’s Disease. In: Giacobini, E., Ed., Its Function and Inhibition, Martin Dunitz Ltd., London, 69-90.
- Lahiri, D.K., Rogers, J.T., Sambamurti, K. and Greig, N.H. (2004) Rationale for the Development of Cholinesterase Inhibitors as Anti-Alzheimer Agents. Current Pharmaceutical Design, 10, 3111-3119. https://doi.org/10.2174/1381612043383331
- Cummings, J.L. (2000) Cholinesterase Inhibitors: A New Class of Psychotropic Compounds. American Journal of Psychiatry, 157, 4-15. https://doi.org/10.1176/ajp.157.1.4
- Greig, N.H., Pei, X.-F., Soncrant, T.T., Ingram, D.K. and Brossi, A. (1995) Phenserine and Ring C Hetero-Analogs: Drug Candidates for the Treatment of Alzheimer’s Disease. Medicinal Research Reviews, 15, 3-31. https://doi.org/10.1002/med.2610150103
- Blois, M.S. (1958) Antioxidant Determinations by the Use of a Stable Free Radical. Nature, 181, 1199-1200. https://doi.org/10.1038/1811199a0
- Ellmans, G.L., Courtney, K.D., Andress, V.J. and Featherstone, R.M. (1961) A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochemical Pharmacology, 7, 88-95. https://doi.org/10.1016/0006-2952(61)90145-9
- Kang, H.S., Kim, H.R., Byun, D.S., Son, B.W., Nam, T.J. and Choi, J.S. (2004) Tyrosinase Inhibitors Isolated from the Edible Brown Alga Ecklonia stolonifera. Archives of Pharmacal Research, 27, 1226-1232. https://doi.org/10.1007/BF02975886